Children's Healthcare Atlanta/Emory University
Advances in childhood acute myeloid leukemia reviewed
Published in Drug Law Weekly, June 13th, 2006
According to recent research from the United States, "Childhood and adolescent AML is traditionally one of the hardest childhood cancers to successfully treat and had all overall survival well under 10% in the 1960s. Initial progress was made by 3 major events: (1) active chemotherapeutic agents were identified which led to remissions for the first time in this disease; (2) cooperative groups were instituted leading to important clinical trials; and (3) several single institutions began experimenting with the role of allogeneic matched sibling donor (MSD) BMT as effective...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2006-06-13)
More Articles from Drug Law Weekly
- Bipolar Disorder
Study identifies predictors of bipolar disorder risk - Celgene Corporation
Celgene Cellular Therapeutics strengthens intellectual property estate in stem cells - CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals submits more information to USPTO for Oracea patent application - CoolTouch Inc.
CoolTouch Inc. introduces New SaphFire 2.5F fiber for laser vein ablation - Cumberland Emerging Technologies, Inc.
Tennessee university foundation, technologies initiative sign collaboration agreement - Curon Medical, Inc.
Curon and Novasys announce intellectual property transaction - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
